The Heritage Foundation has expressed support for President Donald J. Trump's recent announcement on expanding access to fertility treatments beyond in vitro fertilization (IVF). The announcement focuses on addressing the root causes of infertility, moving away from what some see as the restrictive practices of the fertility industry.
Roger Severino, vice president for domestic policy at The Heritage Foundation, said that President Trump chose not to follow "Obamacare-style mandates and subsidies" in this complex area. Instead, he opened opportunities for treatments that target the underlying causes of infertility, aligning with the Make America Health Again (MAHA) initiative.
Emma Waters, a policy analyst at The Heritage Foundation's Center for Technology and the Human Person, criticized the fertility industry for profiting from couples facing challenges in having children. She noted that "Big Fertility" has resisted expanding access to diverse treatments because it threatens their business model. Waters highlighted that Trump's announcement aims to address these issues by promoting Restorative Reproductive Medicine (RRM), which targets hormone imbalances and other treatable conditions.
The approach is consistent with U.S. Department of Health and Human Services Secretary Robert Kennedy Jr.'s MAHA agenda, emphasizing care that enhances natural fertility and overall health while reducing costs.
For more information on The Heritage Foundation's proposals supporting women and families, visit their website.
Information from this article can be found here.
